Phenazopyridine Hydrochloride NDC 75826-114

NDC codes

FDA NDC Directory

Product NDC (as listed)75826-114Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75826-0114Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75826-114-10	75826011410	100 TABLET in 1 BOTTLE, PLASTIC (75826-114-10)Marketed from Dec 23, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenazopyridine Hydrochloride
Generic name (nonproprietary): phenazopyridine hydrochloride
Active ingredients: Phenazopyridine hydrochloride — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Winder Laboratories, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Dec 23, 2015
Listing expires: Dec 31, 2026
Identifiers: Product ID 75826-114_e0537551-5536-d23c-e053-2995a90af439SPL ID e0537551-5536-d23c-e053-2995a90af439SPL set ID 0a190e86-4074-4822-888e-4952281712eaRxCUI 1094104, 1094107UNII 0EWG668W17UPC 0375826115109, 0375826114102

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475826011410 followed by a unit qualifier and the quantity

Package 75826-0114-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 31, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Phenazopyridine HCl is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of Phenazopyridine HCl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. Because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and Phenazopyridine HCl should be discontinued when symptoms are controlled. The analgesic action may reduce or eliminate the need for systemic analgesics …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)